BASF’s facility is expected to cater to the fast-growing pharmaceutical market in South Asia, with a strong focus on generic drug manufacturing.
Mumbai/India — Recently, BASF India, subsidiary of BASF inaugurated its pharma technical lab at its Innovation Campus Asia Pacific, in Navi Mumbai, India. The facility has been named as the ‘BASF Pharma Solutions Lab’ and is expected to cater to the fast-growing pharmaceutical market in South Asia, with a strong focus on generic drug manufacturing. This segment accounts for more than 70 per cent of the sector in India.
The 200 sq m pharma technical lab is the company’s fifth application lab to be set up among its global innovation network for pharmaceutical solutions. The other four labs have been established in Germany, North America, South America, and Shanghai in China.
The lab has been created with the intention of providing technical capabilities and delivering BASF’s functional solutions for drug formulation, especially in solubilization and instant & modified release. This will enable pharmaceutical manufacturers to solve drug formulation challenges such as developing fixed dose combinations, taste masking and temperature- or moisture-sensitive drugs.
Tina Low, Vice President, BASF Nutrition & Health Asia Pacific says, “We see rapidly rising demand and great opportunities for pharmaceutical solutions in Asia. With our strength in innovation and our comprehensive range of high-quality solutions, we help our customers to meet rising quality and regulatory standards as well as to capture opportunities against increasing competition.” She added, “This technical lab in Mumbai will provide generic drug manufacturing customers with comprehensive solutions for superior product efficacy. It will also optimize the performance of raw materials in formulation.”
Since 2008, BASF has been providing technical services to customers in drug formulation and manufacturing in South Asia. The upgraded pharmaceutical application facility is located within Innovation Campus Asia Pacific (Mumbai), BASF’s biggest research and development (R&D) investment in South Asia. The Innovation Campus Asia Pacific was inaugurated in March 2017 and also comprises the company’s other existing scientific disciplines. This creates the opportunity for innovation synergies to be able to meet the unique technological needs of diverse customers across South Asia.
“South Asia, especially India, is the largest provider for generic medicines globally; and R&D is a major focus for Indian generic pharma companies, as they continue to move further up the value chain to become more competitive globally. The kind of innovation capabilities at this pharma solutions lab for generic drug manufacturing are crucial to furthering the government programs aimed at providing universal healthcare in South Asia,” said Raman Ramachandran, Head South Asia and Chairman and Managing Director, BASF India.